The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 22, 2025
Filed:
May. 25, 2022
Applicant:
Ipsen Biopharm Ltd., Wrexham, GB;
Inventors:
Eliel Bayever, New York, NY (US);
Navreet Dhindsa, Boston, MA (US);
Jonathan Basil Fitzgerald, Arlington, MA (US);
Peter Laivins, Rowayton, CT (US);
Victor Moyo, Ringoes, NJ (US);
Clet Niyikiza, Gulf Mills, PA (US);
Jaeyeon Kim, Lexington, MA (US);
Assignee:
Ipsen Biopharm Ltd., , GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4745 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2025.01); A61K 9/1271 (2025.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 47/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4745 (2013.01); A61K 9/0019 (2013.01); A61K 9/127 (2013.01); A61K 9/1271 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/28 (2013.01);
Abstract
Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.